Related Experiment Video
Updated: Oct 19, 2025

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Systemic Inflammation-Related Bradycardia in COVID-19.
Aswin Srinivasan1, Tusharkumar Pansuriya1, Branden Wilson1
1Department of Internal Medicine, HCA Houston Kingwood/University of Houston College of Medicine, USA.
Systemic inflammation from COVID-19 may cause sinus bradycardia, a slow heart rate. Researchers recommend monitoring patients for hemodynamic changes and avoiding medications that worsen bradycardia.
Area of Science:
- Cardiology
- Infectious Diseases
- Physiology
Background:
- Sinus bradycardia associated with systemic inflammation in COVID-19 is not well-documented.
- Understanding the link between COVID-19 and bradycardia is crucial for patient management.
Observation:
- A case series of six patients with COVID-19 infection and bradycardia was analyzed.
- Common causes of bradycardia were systematically excluded in these patients.
Findings:
- Systemic inflammation in COVID-19 patients can lead to sinus bradycardia.
- Bradycardia may be a potential sequela or complication of COVID-19 infection.
Implications:
- Close hemodynamic monitoring is recommended for COVID-19 patients presenting with bradycardia.
- Clinicians should consider discontinuing medications that may exacerbate bradycardia in this population.
Related Concept Videos
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Myocarditis III: Medical Management
Myocarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis I: Introduction

